Analyst Report: Integrated Proteins Ltd (519606)

1. Announcement Analysis & Ramp-Aware Impact Math

Integrated Proteins reported Q1 FY27 revenue of ₹10.55 Cr, representing a massive surge compared to ₹0.05 Cr in Q1 FY26 and higher than the total FY26 annual revenue of ₹9.94 Cr. Net profit stood at ₹0.36 Cr for the quarter (EPS ₹0.19).

• Ramp-Aware Math:
• Annualized Q1 revenue = ~₹42.2 Cr (vs FY26 revenue of ₹9.94 Cr, an uplift of ~324.5%).
• Operating profit for Q1 FY27 stood at ~₹0.36 Cr (~3.4% margin).
• Annualized PAT = ~₹1.44 Cr -> Annualized EPS = ~₹0.76 (vs FY26 EPS of ₹0.12, an uplift of ~533%).
• At the current market price of ₹135.7 (Market Cap ₹249 Cr), the forward P/E on annualized Q1 earnings is ~173x, while trailing P/E remains extreme at 1130x.

2. Industry Context & Quality Assessment

• Pivot to Textile Segment: 99.6% of Q1 FY27 revenue (₹10.51 Cr) came from Textiles, representing a complete pivot away from Edible Oils. Textile trading/processing is characterized by medium capital intensity, low operating margins (typically 3-6%), and high working capital dependency.
• Quality Metrics: ROCE sits at 1.3%, OPM at 2.4%, and net worth at ₹21 Cr. Fundamental Grade is D due to weak structural profitability.

3. Governance & Risk Constraints (Mandatory Cap Rule)

• Promoter Stake Risk: Promoter holding stands at a dangerously low 2.23% (down from 13.04% in Sep 2025). Per evaluation guardrails, any stock with promoter holding < 35% MUST be capped at POSSIBLE or lower, with confidence <= 0.50.
• Business Model Pivot: An abrupt transition into textile trading with low promoter ownership raises severe red flags regarding revenue quality, counterparty concentration, and corporate governance.

4. Valuation Scenarios & Target Impact

• Bull Case (+30%): Textile revenues scale sustainably to >₹60 Cr annually with margin expansion to 6%, pushing annual PAT to ₹3.6 Cr. Forward P/E compresses towards ~70x.
• Base Case (-20%): Revenue stabilizes around ₹40 Cr with razor-thin net margins (~3%), yielding PAT of ~₹1.2-1.5 Cr. Stock de-rates towards realistic industry multiples (Peer median P/E is 22.9x).
• Bear Case (-60%): Revenue jump proves to be a temporary pass-through trading spike, margins compress back to near-zero, and lack of promoter backing leads to significant price destruction.

5. Final Verdict & Recommendation

While the Q1 earnings show a dramatic top-line surge, the combination of an abrupt business pivot, razor-thin margins, an extreme valuation (>170x forward P/E), and a critical promoter holding of just 2.23% makes this an UNLIKELY multibagger candidate. Confidence is set low at 0.35.